Home

Parenteral Drugs (india) Ltd Quarterly Result

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

Net Profit - Last Quarter

₹ 23.81 Cr.

Last updated on: May 12, 2025

Parenteral Drugs (India) Ltd Quarterly Results Key Highlights

No data available

Parenteral Drugs (India) Ltd Quarterly Results Analysis

Market Price of Parenteral Drugs (India) Ltd

1M

1Y

3Y

5Y

Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20233.39
14 Aug 20233.24
24 Jul 20233.09
17 Jul 20233.25
10 Jul 20233.42
03 Jul 20233.59
26 Jun 20233.77
19 Jun 20233.96
12 Jun 20233.85
05 Jun 20234.05

Historical Revenue of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Parenteral Drugs (India) Ltd

What key financial metrics are included in Parenteral Drugs (India) Ltd's quarterly results?

Key financial metrics in Parenteral Drugs (India) Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Parenteral Drugs (India) Ltd announce its quarterly results?

Parenteral Drugs (India) Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Parenteral Drugs (India) Ltd's quarterly performance impact its stock price?

Parenteral Drugs (India) Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Parenteral Drugs (India) Ltd's quarterly results on dividends?

The impact of Parenteral Drugs (India) Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Parenteral Drugs (India) Ltd's quarterly results?

Yes, Parenteral Drugs (India) Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions